Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Alexander Drilon

Name: Activity of zidesamtinib for ROS1+ NSCLC in TKI-naïve and pre-treated patients
Uploaded: 2026-10-07T00:00:00Z
Duration: 52 s

Sorry, no posts matched your criteria.

Alexander Drilon

Cookie settings